ISENTRESS 25 mg/1

Isentress 25 mg chewable tablets contain raltegravir, an antiretroviral medication used to manage HIV. This oral treatment is designed for convenient administration, offering a chewable form for ease of use.

Isentress 25 mg chewable tablets are primarily used as part of antiretroviral therapy to manage HIV infection. Raltegravir works by inhibiting the integrase enzyme, which is essential for the virus to replicate. This medication is often prescribed in combination with other antiretroviral drugs to help control HIV and reduce the risk of disease progression. What is Isentress used for? It is used to treat HIV in adults and children, providing a crucial component in the management of the virus.

Common effects of Isentress 25 mg chewable tablets may include headache, dizziness, nausea, and fatigue. Some users might experience mild gastrointestinal discomfort or changes in sleep patterns. These effects are generally temporary and may vary among individuals. It is important to consult a healthcare provider if any persistent or severe side effects occur.

Isentress 25 mg chewable tablets should be stored at room temperature, away from moisture and heat. Always follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication is intended for oral use and should not be shared with others. Keep out of reach of children and pets.

Isentress 25 mg chewable tablets may interact with certain medications, including antacids, rifampin, and other drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate certain side effects.